Cannabis

Home / Industries / Cannabis
All industries
Regulated Industries · Cannabis

Cannabis businesses get legal counsel on the conflicting patchwork of state and federal law, plus brand protection and deal structuring, from attorneys who understand both the regulatory traps and the IP limits that come with a federally illegal product.

The cannabis industry keeps growing even though state legalization and federal prohibition still collide. You might cultivate, manufacture, sell, invest, or supply the businesses that do, and every one of those roles runs into rules that change by state and contradict federal law. We provide counsel to operators, investors, and ancillary companies that need to expand while staying compliant in a market where the legal ground keeps shifting.

State Licensing and Compliance

Cannabis regulation is intensely state-specific, and the details decide whether you keep your license. We advise on licensing and permitting, ongoing operational compliance, testing and labeling requirements, and seed-to-sale tracking obligations. When regulators come asking questions or initiate enforcement, we respond on your behalf. As you move into new states, we map each program separately so an expansion does not import assumptions that simply do not apply there.

Brand and IP Protection

Protecting cannabis IP runs into a wall: federal trademark registration is largely off the table for plant-touching goods. We build trademark strategies that use ancillary goods, state registrations, and related marks to protect your brand anyway, safeguard cultivation methods and recipes as trade secrets, and advise on plant patents and variety protection where they fit. We are candid about the federal limits so you invest in protection that will actually hold.

Deals and Financing

Cannabis transactions carry structuring problems most industries never see, from banking constraints to multistate operator setups. We advise on mergers and acquisitions, investment structures, cannabis-specific financing, real estate arrangements, and MSO frameworks. We draft deals that account for the regulatory and federal-law realities up front, so the structure that looks clean on paper does not collapse the moment it meets a state licensing rule or a lender's compliance review.

Frequently asked questions

Not for products that violate federal law, because the USPTO refuses registration for marks used on federally illegal goods, and marijuana remains controlled at the federal level. Many businesses instead build protection through state trademark registrations, common-law rights from actual use, and federal registrations for lawful related goods and services, such as clothing or hemp-derived products that meet federal definitions. A layered strategy gives you enforceable brand rights even without a full federal mark on the plant itself.

Treat compliance as state-specific and assume no safe harbor from federal law. State programs impose detailed licensing, seed-to-sale tracking, packaging, and advertising rules that vary widely, and a misstep can cost your license. Federal illegality also creates collateral problems, including limited banking access and the tax treatment under Section 280E that disallows many ordinary business deductions, so plan your structure and recordkeeping with both layers in mind.

Yes, federal illegality of a product does not by itself bar a patent, and the USPTO has granted patents on cannabis plants, extraction methods, formulations, and devices. The usual requirements still apply: the invention must be novel, non-obvious, and properly described. Patents can be a strong asset in this industry precisely because trademark protection is limited, so it's worth identifying patentable processes and formulations early.

Because the product is federally illegal, many standard arrangements carry extra risk, so structure carefully. Watch for ownership and residency restrictions in state licenses, transfer rules that require regulator approval, and contracts that may be hard to enforce if a court views them as furthering illegal activity. Investors also scrutinize banking, tax, and licensing exposure, so clean compliance and clear deal terms directly affect whether financing comes together.

Our team

Attorneys for this industry

Document products

Related document products

Order attorney-drafted documents related to this industry.

Browse all products

Protecting innovation in cannabis.

Get in touch